Corrigendum to “Kaempferol attenuates viability of ex-vivo cultured post-NACT breast tumor explants through downregulation of p53 induced stemness, inflammation and apoptosis evasion pathways” Pathol. - Res. Pract. 237 (2022) 154029

IF 3.2 4区医学 Q2 PATHOLOGY Pathology, research and practice Pub Date : 2024-09-01 Epub Date: 2024-08-07 DOI:10.1016/j.prp.2024.155435

Sourav Kumar Nandi , Ayan Pradhan , Basudeb Das , Biswajit Das , Sudarshana Basu , Bibekanand Mallick , Amitava Dutta , Diptendra Kumar Sarkar , Ashis Mukhopadhyay , Soma Mukhopadhyay , Rittwika Bhattacharya

引用次数: 0

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

对 "山奈酚通过下调 p53 诱导的干性、炎症和凋亡规避途径，削弱体内外培养的 NACT 后乳腺肿瘤外植体的活力 "的更正：《病理学研究与实践》（Pathol.- Res. Pract.237 (2022) 154029.

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Pathology, research and practice 医学-病理学

CiteScore

5.00

自引率

3.60%

发文量

405

审稿时长

24 days

期刊介绍： Pathology, Research and Practice provides accessible coverage of the most recent developments across the entire field of pathology: Reviews focus on recent progress in pathology, while Comments look at interesting current problems and at hypotheses for future developments in pathology. Original Papers present novel findings on all aspects of general, anatomic and molecular pathology. Rapid Communications inform readers on preliminary findings that may be relevant for further studies and need to be communicated quickly. Teaching Cases look at new aspects or special diagnostic problems of diseases and at case reports relevant for the pathologist''s practice.